Norsyahida Mohd Fauzi

Dr. Norsyahida Mohd Fauzi

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ARAnand Ramalingam
Anand Ramalingam
SBSiti Balkis Budin
Siti Balkis Budin
NFNorsyahida Mohd Fauzi
Norsyahida Mohd Fauzi
RRRebecca H. Ritchie
Rebecca H. Ritchie
SZSatirah Zainalabidin
Satirah Zainalabidin
Long-term nicotine intake is associated with an increased risk of myocardial damage and dysfunction. However, it remains unclear whether targeting mitochondrial reactive oxygen species (ROS) prevents nicotine-induced cardiac remodeling and dysfunction. This study investigated the effects of mitoTEMPO (a mitochondria-targeted antioxidant), and resveratrol (a sirtuin activator) , on nicotine-induced cardiac remodeling and dysfunction. Sprague–Dawley rats were administered 0.6 mg/kg nicotine daily with 0.7 mg/kg mitoTEMPO, 8 mg/kg resveratrol, or vehicle alone for 28 days. At the end of the study, rat hearts were collected to analyze the cardiac structure, mitochondrial ROS level, oxidative stress, and inflammation markers. A subset of rat hearts was perfused ex vivo to determine the cardiac function and myocardial susceptibility to ischemia–reperfusion injury. Nicotine administration significantly augmented mitochondrial ROS level, cardiomyocyte hypertrophy, fibrosis, and inflammation in rat hearts. Nicotine administration also induced left ventricular dysfunction, which was worsened by ischemia–reperfusion in isolated rat hearts. MitoTEMPO and resveratrol both significantly attenuated the adverse cardiac remodeling induced by nicotine, as well as the aggravation of postischemic ventricular dysfunction. Findings from this study show that targeting mitochondrial ROS with mitoTEMPO or resveratrol partially attenuates nicotine-induced cardiac remodeling and dysfunction.

1 August 2015 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
NFNorsyahida Mohd Fauzi
Norsyahida Mohd Fauzi
JLJian Sian Lee
Jian Sian Lee
SBSyed Nasir Abbas Bhukari
Syed Nasir Abbas Bhukari
Effects of chalcone derivatives on players of the immune system Jian Sian Lee, Syed Nasir Abbas Bukhari, Norsyahida Mohd Fauzi Drug and Herbal Research Center, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia The immune system is the defense mechanism in living organisms that protects against the invasion of foreign materials, microorganisms, and pathogens. It involves multiple organs and tissues in human body, such as lymph nodes, spleen, and mucosa-associated lymphoid tissues. However, the execution of immune activities depends on a number of specific cell types, such as B cells, T cells, macrophages, and granulocytes, which provide various immune responses against pathogens. In addition to normal physiological functions, abnormal proliferation, migration, and differentiation of these cells (in response to various chemical stimuli produced by invading pathogens) have been associated with several pathological disorders. The unwanted conditions related to these cells have made them prominent targets in the development of new therapeutic interventions against various pathological implications, such as atherosclerosis and autoimmune diseases. Chalcone derivatives exhibit a broad spectrum of pharmacological activities, such as immunomodulation, as well as anti-inflammatory, anticancer, antiviral, and antimicrobial properties. Many studies have been conducted to determine their inhibitory or stimulatory activities in immune cells, and the findings are of significance to provide a new direction for subsequent research. This review highlights the effects of chalcone derivatives in different types of immune cells. Keywords: macrophages, neutrophils, T-cells

27 November 2020 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
JTJiah Ning Tan
Jiah Ning Tan
SSShamin Mohd Saffian
Shamin Mohd Saffian
FBFhataheya Buang
Fhataheya Buang
ZJZakiah Jubri
Zakiah Jubri
IJIbrahim Jantan
Ibrahim Jantan
NFNorsyahida Mohd Fauzi
Norsyahida Mohd Fauzi
Background:Gynura species have been used traditionally to treat various ailments, such as fever, pain, and to control blood glucose level. This systematic review critically discusses studies regarding Gynura species that exhibited antioxidant and anti-inflammatory effects, thus providing perspectives and instructions for future research of the plants as a potential source of new dietary supplements or medicinal agents.Methods: A literature search from internet databases of PubMed, Scopus, Science Direct, e-theses Online Service, and ProQuest was carried out using a combination of keywords such as “Gynura,” “antioxidant,” “anti-inflammatory,” or other related words. Research articles were included in this study if they were experimental (in vitro and in vivo) or clinical studies on the antioxidant or anti-inflammatory effects of Gynura species and if they were articles published in English.Results: Altogether, 27 studies on antioxidant and anti-inflammatory effects of Gynura species were selected. The antioxidant effects of Gynura species were manifested by inhibition of reactive oxygen species production and lipid peroxidation, modulation of glutathione-related parameters, and enzymatic antioxidant production or activities. The anti-inflammatory effects of Gynura species were through the modulation of inflammatory cytokine production, inhibition of prostaglandin E2 and nitric oxide production, cellular inflammatory-related parameters, and inflammation in animal models. The potential anti-inflammatory signaling pathways modulated by Gynura species are glycogen synthase kinase-3, nuclear factor erythroid 2-related factor 2, PPARγ, MAPK, NF-κB, and PI3K/Akt. However, most reports on antioxidant and anti-inflammatory effects of the plants were on crude extracts, and the chemical constituents contributing to bioactivities were not clearly understood. There is a variation in quality of studies in terms of design, conduct, and interpretation, and in-depth studies on the underlying mechanisms involved in antioxidant and anti-inflammatory effects of the plants are in demand. Moreover, there is limited clinical study on antioxidant and anti-inflammatory effects of Gynura species.Conclusion: This review highlighted antioxidant and anti-inflammatory effects of genus Gynura and supported their traditional uses to treat oxidative stress and inflammatory-related diseases. This review is expected to catalyze further studies on genus Gynura. However, extensive preclinical data need to be generated from toxicity and pharmacokinetic studies before clinical studies can be pursued for their development into clinical medicines to treat oxidative stress and inflammatory conditions.

16 May 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
JTJiah Ning Tan
Jiah Ning Tan
KHKhairana Husain
Khairana Husain
ZJZakiah Jubri
Zakiah Jubri
KCKok Meng Chan
Kok Meng Chan
IJIbrahim Jantan
Ibrahim Jantan
NFNorsyahida Mohd Fauzi
Norsyahida Mohd Fauzi

31 August 2019 in Sains Malaysiana
Verified
Journal Article
Closed access
JTJiah Ning Tan
Jiah Ning Tan
SYSyaratul Dalina Yusoff
Syaratul Dalina Yusoff
ZJZakiah Jubri
Zakiah Jubri
FBFhataheya Buang
Fhataheya Buang
ZTZe Song Tan
Ze Song Tan
NFNorsyahida Mohd Fauzi
Norsyahida Mohd Fauzi

25 February 2024 in Saudi Journal of Biological Sciences
Verified
Journal Article
Open access
IFInarah Fajriaty
Inarah Fajriaty
IFIrda Fidrianny
Irda Fidrianny
NKNeng Fisheri Kurniati
Neng Fisheri Kurniati
NFNorsyahida Mohd Fauzi
Norsyahida Mohd Fauzi
SMSarmila Hanim Mustafa
Sarmila Hanim Mustafa
IAI K. Adnyana
I K. Adnyana
• The prevalence cardiovascular disease can be reduced by using cytotoxic, antioxidant, and HMG-CoA reductase inhibitory drugs. • In vitro studies showed the extracted Chitin was found to have cytotoxic, antioxidant, and HMG CoA reductase inhibitor activities. • In silico study, simulasi MD (100 ns) chitin remained stable in the active sites of the HMG CoA reductase receptor. • Chitin from mangrove crab (Scylla serrata) shells can be used to develop more potent for effective dyslipidemia therapy.